(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has granted priority review for its immunotherapy drug Imfinzi for some cancer forms.

Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S. These include ...

ChatGPT launched the chatbot era in November 2022, but despite its huge popularity the conversational interface limited what ...

We are entering the third phase of generative AI. First came the chatbots, followed by the assistants. Now we are beginning to see agents.

Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...

This submission represents the third accepted application for ivonescimab in China, following previous filings for its combination therapy in EGFR-TKI resistant locally advanced or metastatic ...

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has introduced its ...

A 2019 study found that every two hours in the US, a child was taken to hospital because of accidental exposure to cosmetic ...

Modern radiotherapy faces two critical challenges: overcoming biological heterogeneity and enhancing physical precision beyond anatomical constraints.